Comparison Of Diacerein-Ginger With Diacerein Alone In Treating Knee Osteoarthritis
DOI:
https://doi.org/10.51985/JBUMDC2019096Keywords:
knee, osteoarthritis, ginger, diacerein, WOMAC score, pain scoreAbstract
Objective: To compare clinical efficacy of diacerein-ginger with diacerein alone in treating knee osteoarthritis.
Duration and place of study: It was a randomized clinical trial conducted from 21st September 2018 to 31stMarch 2019,
in medical OPD of a private hospital in Karachi.
Methodology: 60 diagnosed patients of knee osteoarthritis were included in this study. Male and female patients 50 years
of age, fulfilling the inclusion criteria and after written informed consent experienced a wash-out period of 72 hours. These
patients were systematically randomized into 2 groups each having 30 members. Group A received capsule Diacerein 50mg
+ capsule Ginger 550 mg twice daily and group B received capsule Diacerein 50mg twice daily, for 12 weeks. Parameters
checked at 0, 6 and 12 weeks were: Western Ontario and McMaster Universities Osteoarthritis (WOMAC) index, pain at
rest and movement (Visual Analogue Scale). Comparison of the two groups was done by independent t-test.
Results: Among 60 patients; 20 (33.33 %) were males and 40 (66.66%) were females. 4 patients in group A and 4 in B,
dropped out during the study. Comparison of group A with group B in WOMAC and pain (at rest and movement) scores
showed insignificant difference at day 0 before prescription of the drugs. However comparison showed highly significant
difference (P-value < 0.001) between the two groups in WOMAC, pain at rest and movement scores at the end of 6th and
12th weeks of intervention.
Conclusion: Diacerein-Ginger is clinically more efficacious for management of knee OA than Diacerein alone.
References
Maly MR, Robbins SM. Osteoarthritis year in review 2015: Rehabilitation and outcomes. Osteoarthr Cartil. 2016; 24(12): 58–70.
Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, et al. The global burden of hip and knee osteoarthritis: Estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. 2014; 73(7): 1323–30.
Vincent TL, Watt FE. Osteoarthritis. Medicine. 2018; 46(3): 187-195. doi: 10.1016/j.mpmed.2017.12.009.
Vina ER, Kwoh CK. Epidemiology of Osteoarthritis: Literature Update. Curr Opin Rheumatol. 2018; 30(2): 160–167. doi: 10.1097/BOR.0000000000000479.
Rahmati M, Mobasheri A, Mozafari M. Inflammatory mediators in osteoarthritis: A critical review of the state-of-the-art, current prospects, and future challenges. Bone. 2016; 85: 81–90. doi: 10.1016/j.bone.2016.01.019.
Wojdasiewicz P, Poniatowskim LA, Szukiewicz D. The role of inflammatory an anti-inflammatory cytokines in the pathogenesis of osteoarthritis. Mediators Inflamm. 2014; Article ID 561459. doi: 10.1155/2014/561459.
Sharma L. Osteoarthritis year in review 2015: clinical. Osteoarthritis Cartilage. 2016; 24(1): 36–48.
Alshami AM. Knee osteoarthritis related pain: a narrative review of diagnosis and treatment. Intern J Health Sci. 2014; 8(1): 85-104.
Altman R, Alarcon G, Appelrouth D, Bloch D, Borenstein D, Brown C, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum.1986; 29 (8): 1039-49.
Pereira D, Ramos E, Branco J. Osteoarthritis. Acta Med Port, 2015; 28(1): 99–106.
Nakata K, Hanai T, Take Y, Osada T, Tsuchiya T, Shima D, et al. Disease-modifying effects of COX-2 selective inhibitors and non-selective NSAIDs in osteoarthritis: a systematic review. Osteoarthritis Cartilage. 2018; 26(10): 1263-73. doi: 10.1016/j.joca.2018.05.021.
Pavelka K, Bruyère O, Cooper C, Kanis JA, Leeb BF, Maheu E, et al. Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO. Drugs Aging. 2016; 33(2): 75-85.
Fidelix TS, Macedo CR, Maxwell LJ, Fernandes Moça Trevisani V. Diacerein for osteoarthritis. Cochrane Database of Systematic Reviews. 2014; 10 (2). Art. No.: CD005117. doi: 10.1002/14651858.CD005117.pub3
McAlindon TE, Bannuru RR, Sullivan MC, Arden NK, Berenbaum, F, Bierma-Zeinstra SM, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014; 22(3): 363–88.
Therkleson T. Topical ginger treatment with a compress or patch for osteoarthritis symptoms. J Holist Nurs. 2014; 32(3): 173–82. doi: 10.1177/0898010113512182.
Haniadka R, Saldanha E, Sunita V, Palatty PL, Fayad R, Baliga MS. A review of the gastroprotective effects of ginger (Zingiber officinale Roscoe). Food Funct. 2013; 4(6): 845–55.
Vaishya R, Agarwal A K, Shah A, Vijay V, Vaish A. Current status of top 10 nutraceuticals used for Knee Osteoarthritis in India. J Clin Orthop Trauma. 2018; 9 (4): 338-48.
Kallgren JH, & Lawrence JS. Radiological assessment of osteoarthritis. Ann Rheum Dis, 1956; 16(3): 494–503.
Pal CP, Singh P, Chaturvedi S, Pruthi KK, Vij A. Epidemiology of knee osteoarthritis in India and related factors. Ind J Orthop. 2016; 50(5): 518–22.
Prashansanie Hettihewa A, Gunawardena NS, Atukorala I, Hassan F, Lekamge IN, Hunt DJ. Prevalence of knee osteoarthritis in a suburban, Srilankan, adult female population: a population-based study. Int J Rheum Dis. 2018; 21(2): 394-401.
Alipour Z, Asadizaker M, Fayazi S, Yegane N, Kochak M, Hossein M. The Effect of Ginger on Pain and Satisfaction of Patients with Knee Osteoarthritis. JJ Chron Dis Care. 2017; 6(1): e34798. doi: 10.17795/jjcdc-34798.
Naderi Z, Mozaffari-Khosravi H, Dehghan A, FallahHosseini H, Nadjarzadeh A. The Effect of Ginger (Zingiber Officinale) Powder Supplement on Pain in Patients with Knee Osteoarthritis: a Double-Blind Randomized Clinical Trial. J Shahid Sadoughi Un Med Sci. 2013; 20 (5): 657-67.
Paramdeep G. Efficacy and tolerability of ginger (Zingiber Officinale) in patients of osteoarthritis of knee. Ind J PhysPharmacol. 2013; 57(2): 177–83.
Bartels EM, Folmer VN, Bliddal H, Altman RD, Juhl C, Tarp S, et al. Efficacy and safety of ginger in osteoarthritis patients: A meta-analysis of randomized placebo-controlled trials. Osteoarthritis Cartilage. 2015; 23(1): 13–21.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Mehtab Munir, Shahid Mustafa Memon, Sajid Abbas Jaffri, Khalid Mustafa Memon
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of Bahria University Medical & Dental College is an open access journal and is licensed under CC BY-NC 4.0. which permits unrestricted non commercial use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0 
